Magdalena Zaborowska-Szmit

5PUBLICATIONS
7CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Gene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jul 08, 2024
The combination of osimertinib and savolitinib as molecular inhibition of EGFR and MET receptors may be selected to provide maximum effectiveness and acceptable toxicity.

Dariusz M Kowalski, Magdalena Zaborowska-Szmit, Sebastian Szmit

|Mar 29, 2023
Nivolumab or Atezolizumab in the Second-Line Treatment of Advanced Non-Small Cell Lung Cancer? A Prognostic Index Based on Data from Daily Practice.

Magdalena Knetki-Wróblewska, Sylwia Tabor, Aleksandra Piórek

|Feb 25, 2023
Beta Blockers with Statins May Decrease All-Cause Mortality in Patients with Cardiovascular Diseases and Locally Advanced Unresectable Non-Small-Cell Lung Cancer after Chemoradiotherapy.

Magdalena Zaborowska-Szmit, Sebastian Szmit, Marta Olszyna-Serementa

|Feb 24, 2023
Performance-Status Deterioration during Sequential Chemo-Radiotherapy as a Predictive Factor in Locally Advanced Non-Small Cell Lung Cancer.

Marta Olszyna-Serementa, Magdalena Zaborowska-Szmit, Sebastian Szmit

|Feb 22, 2023
Savolitinib for non-small cell lung cancer.

Magdalena Zaborowska-Szmi, Sebastian Szmit, Maciej Krzakowski

Pageof 1

Frequent Collaborators

5 joint publications

Dariusz M Kowalski

4 joint publications

Sebastian Szmit

2 joint publications

Maciej Krzakowski

2 joint publications

Aleksandra Piórek